- Home
- PRPO vs PPBT Comparison
PRPO vs PPBT Comparison
Compare PRPO & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- PPBT
- Stock Information
- Founded
- PRPO N/A
- PPBT 2010
- Country
- PRPO United States
- PPBT Israel
- Employees
- PRPO N/A
- PPBT N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- PRPO Industrials
- PPBT Health Care
- Exchange
- PRPO Nasdaq
- PPBT Nasdaq
- Market Cap
- PRPO 9.5M
- PPBT 9.2M
- IPO Year
- PRPO N/A
- PPBT N/A
- Fundamental
- Price
- PRPO $6.25
- PPBT $2.68
- Analyst Decision
- PRPO
- PPBT Strong Buy
- Analyst Count
- PRPO 0
- PPBT 2
- Target Price
- PRPO N/A
- PPBT $126.50
- AVG Volume (30 Days)
- PRPO 7.5K
- PPBT 61.3K
- Earning Date
- PRPO 11-06-2024
- PPBT 11-19-2024
- Dividend Yield
- PRPO N/A
- PPBT N/A
- EPS Growth
- PRPO N/A
- PPBT N/A
- EPS
- PRPO N/A
- PPBT N/A
- Revenue
- PRPO $17,411,000.00
- PPBT N/A
- Revenue This Year
- PRPO $75.18
- PPBT N/A
- Revenue Next Year
- PRPO N/A
- PPBT N/A
- P/E Ratio
- PRPO N/A
- PPBT N/A
- Revenue Growth
- PRPO 31.31
- PPBT N/A
- 52 Week Low
- PRPO $4.31
- PPBT $2.50
- 52 Week High
- PRPO $8.49
- PPBT $23.20
- Technical
- Relative Strength Index (RSI)
- PRPO 52.41
- PPBT 29.43
- Support Level
- PRPO $6.14
- PPBT $2.50
- Resistance Level
- PRPO $6.47
- PPBT $2.82
- Average True Range (ATR)
- PRPO 0.19
- PPBT 0.37
- MACD
- PRPO 0.01
- PPBT 0.04
- Stochastic Oscillator
- PRPO 88.00
- PPBT 4.66
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.